£100
No changevs Jun 2024Active14598322Private limited companyLondon
BRANCHPOINT THERAPEUTICS LTD
Significant control: Olga Artemyeva Isman (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Branchpoint Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Branchpoint Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BRANCHPOINT THERAPEUTICS LTD is an active private limited company (company number 14598322) incorporated on 17 January 2023, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 30 June 2025, showing net assets of £100, with 0 employees on average. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Mrs Olga Artemyeva Isman
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 17 January 20233 yrs ago
- Next accounts due
- 30 March 2027in 155 days
- Confirmation statement due
- 31 January 2027in 97 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
0
vs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £100 | — | — | — | — | — | 0 |
| 30 June 2024 | £100 | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £100 at 30 June 2025
- Incorporated two to five years agoIncorporated 17 January 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 155 days
- Confirmation statement duein 97 days
- Accounts period endNet assets £100 · dormant accounts
- Accounts period endNet assets £100 · dormant accounts
- Incorporated
08
Similar companies in London
- TRANSNETYX LIMITEDLondon · inc. Jan 2023
- LIGHTBEAM BIOTECH LTDLondon · inc. Jan 2023
- CONCEIVABLE LIFE SCIENCES LIMITEDLondon · inc. Jan 2023
- CORNEA VENTURES LIMITEDLondon · inc. Jan 2023
- PRECISION PLANTS LTDLondon · inc. Feb 2023
- AFI CLINICAL DEVELOPMENT LTDLondon · inc. Dec 2022
All companies incorporated on 17 January 2023 · in Jan 2023.
09
Reminders for BRANCHPOINT THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.